Cas:12293-61-7 magnesium tantalum oxide manufacturer & supplier

We serve Chemical Name:magnesium tantalum oxide CAS:12293-61-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

magnesium tantalum oxide

Chemical Name:magnesium tantalum oxide
CAS.NO:12293-61-7
Synonyms:MFCD00210633;EINECS 235-562-8;magnesium ditantalum hexaoxide;MAGNESIUM TANTALATE
Molecular Formula:MgO6Ta2
Molecular Weight:482.19700
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:94.58000
Exact Mass:481.85100
LogP:

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like MFCD00210633 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MAGNESIUM TANTALATE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MAGNESIUM TANTALATE Use and application,MFCD00210633 technical grade,usp/ep/jp grade.


Related News: China’s pharmaceutical CMO market has recently maintained a growth rate of more than 10%. From the perspective of market structure, the average growth rate of clinical production is 9.5%, while the average growth rate of commercial production will reach 18.7%. magnesium tantalum oxide manufacturer The slowdown of pesticide intermediates has dragged down the growth of industrial business. In the future, the pharmaceutical intermediate business will be the focus of the company’s development. magnesium tantalum oxide supplier China’s pharmaceutical CMO market has recently maintained a growth rate of more than 10%. From the perspective of market structure, the average growth rate of clinical production is 9.5%, while the average growth rate of commercial production will reach 18.7%. magnesium tantalum oxide vendor China’s pharmaceutical CMO market has recently maintained a growth rate of more than 10%. From the perspective of market structure, the average growth rate of clinical production is 9.5%, while the average growth rate of commercial production will reach 18.7%. magnesium tantalum oxide factory Active pharmaceutical ingredients affect the structure and function of the human body. Inactive ingredients in a pharmaceutical may be referred to as bulk pharmaceutical chemicals (BPCs).